The cypionate-versus-enanthate question is one of the most common in TRT circles, and the honest answer is more nuanced, and more interesting, than mos
Trials on stroke and traumatic brain injuries with competitive glutamate or glycine antagonists (i.e., selfotel, aptiganel, eliprodil, licostinel, and gavestinel) have failed ( ALCAR Acetyl-L-carnitine (-trimethyl--acetylbutyrrobetaine) is an acetyl ester of carnitine, an endogenous molecule with pleiotropic biological and pharmacological activities on central and peripheral nervous systems (Tolu et al., 2002
The main advantage of GLP-1s compared to previous treatments is that the rate of response is very high across the board. Azagury and Ali both noted that side effects are not necessarily dependent on someones health conditions and that they can vary greatly from person to person
Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)